Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 8 studies | 29% ± 9% | |
oligodendrocyte precursor cell | 7 studies | 31% ± 13% | |
glutamatergic neuron | 4 studies | 33% ± 16% | |
endothelial cell | 3 studies | 21% ± 7% | |
GABAergic neuron | 3 studies | 34% ± 13% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 34% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 5311.47 | 2642 / 2642 | 100% | 44.45 | 705 / 705 |
thymus | 100% | 1748.86 | 651 / 653 | 100% | 15.28 | 604 / 605 |
prostate | 100% | 2356.70 | 245 / 245 | 99% | 18.34 | 499 / 502 |
adrenal gland | 100% | 1808.14 | 258 / 258 | 99% | 22.61 | 228 / 230 |
esophagus | 100% | 2149.71 | 1443 / 1445 | 99% | 13.32 | 181 / 183 |
uterus | 100% | 1786.95 | 170 / 170 | 99% | 15.07 | 453 / 459 |
breast | 100% | 1259.64 | 457 / 459 | 99% | 12.28 | 1107 / 1118 |
skin | 100% | 2168.50 | 1806 / 1809 | 99% | 15.13 | 466 / 472 |
kidney | 100% | 1848.42 | 89 / 89 | 98% | 11.78 | 882 / 901 |
bladder | 100% | 1940.95 | 21 / 21 | 97% | 11.89 | 488 / 504 |
intestine | 100% | 1801.58 | 964 / 966 | 97% | 8.79 | 510 / 527 |
ovary | 99% | 1259.23 | 178 / 180 | 97% | 12.97 | 419 / 430 |
lung | 99% | 1382.94 | 571 / 578 | 97% | 10.65 | 1123 / 1155 |
stomach | 99% | 1372.45 | 356 / 359 | 95% | 8.93 | 271 / 286 |
pancreas | 63% | 464.61 | 206 / 328 | 99% | 12.54 | 177 / 178 |
liver | 64% | 496.48 | 145 / 226 | 84% | 5.38 | 340 / 406 |
eye | 0% | 0 | 0 / 0 | 100% | 17.15 | 80 / 80 |
spleen | 100% | 1486.17 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 13.45 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 9.88 | 1 / 1 |
muscle | 100% | 1912.70 | 799 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 1700.58 | 1327 / 1335 | 0% | 0 | 0 / 0 |
adipose | 99% | 1209.59 | 1192 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 8.11 | 28 / 29 |
heart | 96% | 1685.81 | 829 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 55% | 516.79 | 512 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_1902018 | Biological process | negative regulation of cilium assembly |
GO_0043547 | Biological process | positive regulation of GTPase activity |
GO_0090630 | Biological process | activation of GTPase activity |
GO_0005515 | Molecular function | protein binding |
GO_0031267 | Molecular function | small GTPase binding |
GO_0005096 | Molecular function | GTPase activator activity |
Gene name | EVI5L |
Protein name | Ecotropic viral integration site 5-like, isoform CRA_a (Epididymis secretory sperm binding protein) Ecotropic viral integration site 5 like EVI5-like protein (Ecotropic viral integration site 5-like protein) |
Synonyms | hCG_22560 |
Description | FUNCTION: Functions as a GTPase-activating protein (GAP) with a broad specificity. . |
Accessions | M0QYX4 ENST00000599036.1 ENST00000270530.8 [Q96CN4-1] Q96CN4 M0R1Y1 ENST00000601766.1 ENST00000538904.7 [Q96CN4-2] A0A384MR55 |